Blossom Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Blossom Wealth Management's PFE Position: Q2 2025 in Review
Blossom Wealth Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 15,153 shares — an estimated $384K sold.
Blossom Wealth Management first reported a position in PFE in Q3 2021 and held it in 15 quarters. The position peaked at $428K in Q4 2022. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Blossom Wealth Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Blossom Wealth Management sold 15,153 Pfizer shares in Q2 2025, an estimated $384K.
- Blossom Wealth Management first reported a position in Pfizer in Q3 2021 and held it in 15 quarters.
- Blossom Wealth Management's Pfizer position peaked at $428K in Q4 2022.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Blossom Wealth Management's 13F filing for Q2 2025, filed 17 Jul 2025.